Mohammad, Daisal A.

HRN: 23-35-77  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/18/2023
07/24/2023
IVT
300mg
Q8h
Open Joint Disclocation
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: